12:04 PM EST - Cronos Group Inc. : Announced that it has entered into a multi-year supply agreement with MediPharm Labs Corp., whereby MediPharm Labs will supply Cronos Group with approximately $30 million of high-quality private label cannabis concentrate over 18 months, and, subject to certain renewal and purchase options, potentially up to $60 million over 24 months. In addition, Cronos Group has selected MediPharm Labs’ state of the art extraction facility in Barrie, Ontario, as a preferred partner to fulfill certain of its processing needs, under a separate tolling arrangement. Cronos Group Inc.
shares T.CRON are trading up $1.13 at $20.47.
